The past few decades have seen an increase in both the role and the complexity of
neoadjuvant therapy for breast cancer. Neoadjuvant therapy was initially described as …

Neoadjuvant systemic chemotherapy is a possible therapeutic approach for the treatment of
locally advanced operable, primarily non-operable or inflammatory breast cancer …

Neoadjuvant systemic breast cancer therapy is the administration of systemic therapy to
eligible breast cancer patients prior to surgery. This treatment modality was developed out of …

Neoadjuvant chemotherapy (NAC) had been developed as a systematic approach before
definitive surgery for the treatment of locally advanced or inoperable breast cancer such as …

Neoadjuvant chemotherapy is standard management for women who have locally advanced
or inflammatory breast cancer, but can be applied to all women who may require …

Neoadjuvant treatment of breast cancer refers to the use of different treatment modalities
prior to surgical excision of the tumor. It has been accepted as a treatment option for patients …

Historically, neoadjuvant chemotherapy was used in an effort to improve the diseasefree
survival in patients with locally advanced breast cancer that was considered inoperable at …

The treatment of breast cancer has evolved from a primary surgical approach with a focus on
local-regional control to multidisciplinary management with an emphasis on systemic …

Preoperative or neoadjuvant chemotherapy is an option in patients with early-stage breast
cancer. Neoadjuvant treatment has been compared with standard, postoperative adjuvant …

BACKGROUND The majority of patients with breast carcinoma receive chemotherapy as a
component of multimodality treatment. Over the past decade, it has become increasingly …